Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
      Biotech

      Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering

      July 23, 2026
      Codexis Announces Pricing of Public Offering of Common Stock
      Biotech

      Codexis Announces Pricing of Public Offering of Common Stock

      July 23, 2026
      Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
      Biotech

      Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm

      July 23, 2026
      argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
      Biotech

      argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update

      July 22, 2026
      Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
      Biotech

      Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

      July 22, 2026
      Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
      Biotech

      Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

      July 22, 2026
      Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
      Biotech

      Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

      July 22, 2026
      Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
      Biotech

      Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

      July 21, 2026
      Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026
      Biotech

      Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026

      July 21, 2026
      ZYUS Announces Database Lock for its Phase 2a UTOPIA-1 Trial, CFO Transition and Continuous Disclosure Update
      Biotech

      ZYUS Announces Database Lock for its Phase 2a UTOPIA-1 Trial, CFO Transition and Continuous Disclosure Update

      July 20, 2026
      1 2 3 … 149 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026